[Diagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill](https://wbbsec.com/opinions-and-features/diagnosing-medicaid-cuts-to-hospitals-in-the-one-big-beautiful-bill-published-in-forbes/)
[Diagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill](https://wbbsec.com/opinions-and-features/diagnosing-medicaid-cuts-to-hospitals-in-the-one-big-beautiful-bill-published-in-forbes/)

President Donald Trump – Will He Become the Drug Price Equalizer?

By:Posted: May 13th, 2025In: Opinions & Features

Published in Forbes, May 13, 2025

Dr. Steve Brozak, President of WBB Securities, has authored a new opinion piece in Forbes exploring President Donald Trump’s evolving role in the fight to lower drug prices in America.

In the article, Dr. Brozak examines:

  • Trump’s past and current positions on drug pricing reform
  • The potential political and market impact of drug price equalization

“The reality is that drug pricing affects every American, and whoever speaks to that challenge in a credible way will command attention,” Brozak writes.

📖 Read the full article on Forbes:
👉 President Donald Trump – Will He Become the Drug Price Equalizer?

This article was written by Dr. Steve Brozak and originally published by Forbes on May 13, 2025.

Recent Posts